Targeting Plasmodium falciparum IspD in the Methyl- d -erythritol Phosphate Pathway: Urea-Based Compounds with Nanomolar Potency on Target and Low-Micromolar Whole-Cell Activity
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Daan Willocx und 16 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for Pharmaceutical Research (HIPS)-Helmholtz Centre for Infection Research (HZI), Campus E8.1, 66123 Saarbrücken, Germany. Hauptthemen laut MEDLINE: Plasmodium falciparum, Antimalarials. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, H2020 Marie Sklodowska-Curie Actions, Deutsches Zentrum f?r Infektionsforschung.
Abstract (Originalsprache)
The methyl-d-erythritol phosphate (MEP) pathway has emerged as an interesting target in the fight against antimicrobial resistance. The pathway is essential in many human pathogens, including Plasmodium falciparum (Pf), but is absent in human cells. In the present study, we report on the discovery of a new chemical class targeting IspD, the third enzyme in the pathway. Exploration of the structure-activity relationship yielded inhibitors with potency in the low-nanomolar range. Moreover, we investigated the whole-cell activity, mode of inhibition, metabolic, and plasma stability of this compound class, and conducted in vivo pharmacokinetic profiling on selected compounds. Lastly, we disclosed a new mass spectrometry (MS)-based enzymatic assay for direct IspD activity determination, circumventing the need for auxiliary enzymes. In summary, we have identified a readily synthesizable compound class, demonstrating excellent activity and a promising profile, positioning it as a valuable tool compound for advancing research on IspD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Helmholtz Institute for Pharmaceutical Research (HIPS)-Helmholtz Centre for Infection Research (HZI), Campus E8.1, 66123 Saarbrücken, Germany.
- Department of Pharmacy, Saarland University, Campus E8.1, 66123 Saarbrücken, Germany.
- OmicScouts GmbH, Lise-Meitner-Straße 30, 85354 Freising, Germany.
- Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, United States.
- Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.
- Universität Basel, Petersplatz 1, 4003 Basel, Switzerland.
ORCID-Profile: Daan Willocx, Lorenzo Bizzarri, Patricia Bravo, Katharina Rox, Markus Fischer, Andreas M Kany, Matthias Witschel, Mostafa M Hamed, Anna K H Hirsch
Förderung
- NIAID NIH HHS
- H2020 Marie Sklodowska-Curie Actions
- Deutsches Zentrum f?r Infektionsforschung
Zitieren
APA
Willocx, D., Bizzarri, L., Alhayek, A., Kannan, D., Bravo, P., Illarionov, B., Rox, K., Lohse, J., Fischer, M., Kany, A. M., Hahne, H., Rottmann, M., Witschel, M., Odom John, A., Hamed, M. M., Diamanti, E., & Hirsch, A. K. H. (2024). Targeting Plasmodium falciparum IspD in the Methyl- d -erythritol Phosphate Pathway: Urea-Based Compounds with Nanomolar Potency on Target and Low-Micromolar Whole-Cell Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00212
Vancouver
Willocx D, Bizzarri L, Alhayek A, Kannan D, Bravo P, Illarionov B, et al. Targeting Plasmodium falciparum IspD in the Methyl- d -erythritol Phosphate Pathway: Urea-Based Compounds with Nanomolar Potency on Target and Low-Micromolar Whole-Cell Activity. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00212
BibTeX
@article{Willocx2024,
author = {Willocx, Daan and Bizzarri, Lorenzo and Alhayek, Alaa and Kannan, Deepika and Bravo, Patricia and Illarionov, Boris and Rox, Katharina and Lohse, Jonas and Fischer, Markus and Kany, Andreas M and Hahne, Hannes and Rottmann, Matthias and Witschel, Matthias and Odom John, Audrey and Hamed, Mostafa M and Diamanti, Eleonora and Hirsch, Anna K H},
title = {Targeting Plasmodium falciparum IspD in the Methyl- d -erythritol Phosphate Pathway: Urea-Based Compounds with Nanomolar Potency on Target and Low-Micromolar Whole-Cell Activity},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00212}
}
EUVIMED